What is ProCell Therapies?
ProCell Therapies specializes in advanced microneedling services, leveraging clinically proven growth factor serums derived from stem cells to significantly enhance skin appearance. Their innovative approach is designed to stimulate the body's innate capacity for producing healthy new skin, making their treatments and devices a trusted choice for aesthetic professionals. The company's offerings encompass a comprehensive suite of services, including in-office treatments, device sales, and specialized educational workshops, catering to the evolving needs of the aesthetic industry.
How much funding has ProCell Therapies raised?
ProCell Therapies has raised a total of $21K across 1 funding round:
Debt
$21K
Debt (2021): $21K with participation from PPP
What's next for ProCell Therapies?
With significant Series B/C stage backing, ProCell Therapies is strategically positioned for accelerated growth. The recent capital injection is expected to fuel further development of their proprietary technologies, expand their market reach, and enhance their educational programs for aesthetic practitioners. This investment underscores confidence in ProCell Therapies' unique value proposition and its potential to capture a larger share of the burgeoning aesthetic and regenerative skincare market.
See full ProCell Therapies company page
